RevMedica becomes the only Endo Stapling Platform accepted into FDA’s STeP. The Company also expands its intellectual property protection with 5 new patents. MIDDLETOWN, Conn., Jan. 22, 2025 /PRNewswire/ — RevMedica™, Inc. is pleased to announce its’ Endo Stapling Platform has been…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.